Table 2 Laboratory characteristics during the onset of the SJIA
|  | ILD (n = 35) | Non-ILD (n = 141) | P value |
|---|---|---|---|
ESR (mm/h) | 74.5 ± 27.3 | 68.9 ± 26.3 | 0.267 |
SF (ng/mL) | 2622.7 ± 3407.9 | 1147.4 ± 1668.1 | 0.018* |
SF > 684 ng/mL, n (%) | 27 (77.1) | 68 (51.5) | 0.006** |
PCT (ng/mL) | 3.4 ± 9.2 | 0.7 ± 2.7 | 0.137 |
CRP (mg/L) | 122.2 ± 62.8 | 79.4 ± 50.8 | 0.000*** |
WBC (×109/L) | 24.0 ± 12.8 | 17.3 ± 8.6 | 0.006** |
ANC (×109/L) | 20.4 ± 11.8 | 13.6 ± 8.2 | 0.003** |
ALC (×109/L) | 2.2 ± 1.1 | 2.8 ± 1.5 | 0.039* |
Lymphopenia#, n (%) | 18 (51.4) | 40 (28.4) | 0.009** |
ALT (U/L) | 34.1 ± 36.9 | 43.7 ± 90.4 | 0.537 |
AST (U/L) | 32.3 ± 15.3 | 45.6 ± 82.3 | 0.343 |
ALP (U/L) | 156.9 ± 63.9 | 170.7 ± 55.4 | 0.204 |
GGT (U/L) | 68.5 ± 82.3 | 39.9 ± 49.6 | 0.056 |
Total protein (g/L) | 66.4 ± 7.1 | 69.0 ± 6.9 | 0.045* |
LDH (U/L) | 586.9 ± 571.8 | 399.0 ± 486.5 | 0.053 |
Serum calcium (mmol/L) | 2.2 ± 0.1 | 2.3 ± 0.2 | 0.082 |
Fibrinogen (g/L) | 5.97 ± 2.12 | 6.59 ± 3.37 | 0.312 |
TG (mmol/L) | 1.3 ± 0.6 | 1.2 ± 0.7 | 0.156 |
IL-6 (pg/mL) | 147.8 ± 372.7 | 41.8 ± 73.1 | 0.221 |
IL-10 (pg/mL) | 12.6 ± 14.2 | 8.9 ± 10.4 | 0.201 |
TNF-α (pg/mL) | 66.5 ± 214.8 | 15.1 ± 17.6 | 0.298 |
CD3+ (%) | 69.4 ± 12.6 | 70.7 ± 10.4 | 0.566 |
CD4 (%) | 36.4 ± 10.1 | 36.6 ± 10.0 | 0.915 |
CD8 (%) | 29.2 ± 8.3 | 29.8 ± 10.9 | 0.778 |
CD16 + 56+ (%) | 10.1 ± 7.8 | 10.4 ± 7.0 | 0.828 |
CD19 (%) | 17.6 ± 10.0 | 16.7 ± 8.3 | 0.618 |
IgG (mg/dL) | 526.5 ± 645.1 | 563.3 ± 666.6 | 0.775 |
IgA (mg/dL) | 98.6 ± 137.7 | 93.4 ± 121.7 | 0.835 |
IgM (mg/dL) | 67.8 ± 81.1 | 73.3 ± 89.5 | 0.750 |
C3 (mg/dL) | 61.7 ± 69.0 | 66.3 ± 74.7 | 0.753 |
C4 (mg/dL) | 14.2 ± 16.4 | 13.4 ± 15.3 | 0.812 |
BNP (pg/mL) | 641.3 ± 785.3 | 780.3 ± 1454.9 | 0.736 |